ENTITY

Nektar Therapeutics (NKTR US)

8

Analysis

Health Care • United States

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.

more

Refresh

22 Sep 2023 04:07

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement

Share

21 Sep 2023 04:11

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement

Share

21 Sep 2023 04:09

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement

Share

21 Sep 2023 04:08

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement

Share

21 Sep 2023 04:07

Statement of changes in beneficial ownership of securities - general instructions (PDF)

Exchange Announcement

Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.16.5

x